Sanctuary Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$746K Sell
3,826
-1,185
-24% -$246K ﹤0.01% 1679
2026
Q1
$1.12M Buy
5,011
+40
+0.8% +$9.97K 0.01% 1269
2025
Q4
$1.2M Sell
4,971
-44
-0.9% -$11.3K 0.01% 1227
2025
Q3
$1.37M Sell
5,015
-349
-7% -$95.3K 0.01% 1114
2025
Q2
$1.38M Sell
5,364
-187
-3% -$44.6K 0.01% 1034
2025
Q1
$1.24M Sell
5,551
-1,117
-17% -$261K 0.01% 1028
2024
Q4
$1.72M Sell
6,668
-597
-8% -$144K 0.01% 940
2024
Q3
$1.77M Buy
7,265
+1,197
+20% +$267K 0.01% 941
2024
Q2
$1.32M Buy
+6,068
New +$1.23M 0.01% 1035

Other funds holding RMD

Sanctuary Advisors's RMD Position: Q2 2026 in Review

Sanctuary Advisors reduced its ResMed (RMD) stake by 24% in Q2 2026, selling an estimated $246K and leaving 3,826 shares worth $746K. The position accounts for ﹤0.01% of the portfolio, ranked #1679.

Sanctuary Advisors first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.77M in Q3 2024. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Sanctuary Advisors held 3,826 shares of ResMed worth $746K as of Q2 2026.
  • Sanctuary Advisors sold 1,185 ResMed shares in Q2 2026, an estimated $246K.
  • ResMed made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #1679 holding.
  • Sanctuary Advisors first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
  • Sanctuary Advisors's ResMed position peaked at $1.77M in Q3 2024.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.